Work

Location, Location, Location: Membranous Nectin-4 as a Biomarker for Enfortumab Vedotin

Year: 2026

Type: article

Source: Clinical Cancer Research

DOI: 10.1158/1078-0432.ccr-26-3193

Authors: James A. Rodrigues, Hikmat Al-Ahmadie, David H. Aggen, David B. Solit

Institution: Memorial Sloan Kettering Cancer Center

Language: English

Topic: Bladder and Urothelial Cancer Treatments

Subfield: Surgery

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W7225201897

FWCI:

Cites:

Cited by:

Related to: 10